Sentence examples for maintenance phase sample from inspiring English sources

Mean SF-12v2 scores at baseline, Week 8, and Month 12 visits for patients in the maintenance phase sample are presented in Table 4.

Specifically, six comparisons were made, by instrument (SF-12, IBDQ, and WPAI) and by sample (acute phase sample, maintenance phase sample).

Mean WPAI UC domain scores at baseline, Week 3, Week 8, and Month 12 visits for patients in the maintenance phase sample are presented in Table 5.

MMRM were also used to analyze WPAI UC mean scores across baseline, Week 3, and Week 8 visits in acute phase sample patients; SF-12v2 and SIBDQ mean scores across baseline, Week 8, and Month 12 visits for maintenance phase sample patients; and WPAI UC mean scores across baseline, Week 3, Week 8, and Month 12 visits for maintenance phase sample patients.

Maintenance phase sample patients' SF-12v2 scores at the Month 12 visit were not statistically significantly different or significantly higher than those of the US general population on all domains (Fig. 2, black bars).

Changes in LS Mean SF-12v2, SIBDQ, and WPAI UC domain scores from Week 8 to Month 12 for patients in the maintenance phase sample who sustained or failed to sustain remission at Month 12 are presented in Table 6.

Descriptive statistics for demographic and clinical characteristics and baseline scores on PRO measures were computed for patients in the acute phase and maintenance phase samples.

Descriptive statistics for baseline sample characteristics, including demographics, clinical characteristics (modified UC-DAI component and total scores), and PRO scores for both the acute phase and maintenance phase samples, are presented in Table 1.

However, the current trial included patients from countries outside of North America and Western Europe, including India, which was most heavily represented among countries, accounting for 27%and30%0% of the acute phase and maintenance phase samples, as well as several Eastern European, African, and South American countries.

During the maintenance phase, additional 12 ml sampling per assessment for biochemistry and hematology only will be drawn at weeks 20, 32, 44, 56, 68, 80 and 92.

Blood samples were drawn at maintenance phase visits to determine OXC and MHD concentrations for population pharmacokinetic (PK) analysis with nonlinear mixed-effects modeling (NONMEM).